Skip to main content
MedPathMedPath Home
Clinical Trials/NCT05767996
NCT05767996
Enrolling by Invitation
N/A

School-based Education and Screening Program With Lipid Screening as a Means to Identify Familial Hyperlipidemia

Poudre Valley Health System1 site in 1 country104 target enrollmentFebruary 1, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsFamilial Hyperlipidemia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Familial Hyperlipidemia
Sponsor
Poudre Valley Health System
Enrollment
104
Locations
1
Primary Endpoint
School-based Education and Screening Program With Lipid Screening as a Means to Identify Familial Hyperlipidemia
Status
Enrolling by Invitation
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Determination of FH status by genetic testing in school age children who have demonstrated elevated cholesterol on baseline screening.

Registry
clinicaltrials.gov
Start Date
February 1, 2023
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gary J. Luckasen, MD

Principal Investigator

University of Colorado Health

Eligibility Criteria

Inclusion Criteria

  • •Elevated cholesterol on baseline screening to use as means of identifying those with an FH variant

Exclusion Criteria

  • •normal cholesterol

Outcomes

Primary Outcomes

School-based Education and Screening Program With Lipid Screening as a Means to Identify Familial Hyperlipidemia

Time Frame: Evaluation of family members over a defined 5 year period

Percentage of school children who have elevated cholesterol related to FH variant

Study Sites (1)

Loading locations...

Similar Trials

Completed
N/A
Educational Follow-up in a Cohort of Children at the Royal Marsden Hospital (RMH)Brain Tumour
NCT00996450Royal Marsden NHS Foundation Trust110
Completed
N/A
Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®Hunter Syndrome
NCT00937794Shire33
Unknown
N/A
Treatment for Amblyopia Under Binocular Conditions Versus the Standard of Care, Monocular Deprivation TreatmentAmblyopia
NCT05185076NovaSight114
Completed
N/A
CURESIGHT BINOCULAR AMBLYOPIA TREATMENT STUDYAmblyopia
NCT04785690NovaSight23
Recruiting
N/A
PAN INDIA Genetics Study of MODYHealth Condition 1: E138- Other specified diabetes mellituswith unspecified complications
CTRI/2019/12/022394Dr V Mohan
School-based Education and Screening... | Clinical Trial